Time to initiation of multidrug-resistant tuberculosis treatment and its relation with outcome in a high incidence district in Lima, Peru

L Otero, A De Orbegoso, A F Navarro, J Ríos, T Párraga, E Gotuzzo, C Seas, P Van der Stuyft

    Research output: Contribution to journalA1: Web of Science-article

    Abstract

    OBJECTIVE: To determine the time from diagnosis to start of multidrug resistant tuberculosis (MDR TB) treatment in Lima, Peru.

    METHODS: We studied new smear-positive TB adults that were started on MDR TB treatment or that were switched to it between June 2008 and December 2011.

    RESULTS: Time from the first positive smear to MDR-TB treatment was >30 days in 35% (13/37) of patients. Among the 27% (24/88) of patients that switched to MDR-TB treatment, time from the last dose of a drug-susceptible regimen was >30 days.

    CONCLUSION: Start of and switching to MDR TB treatment is still delayed.

    Original languageEnglish
    JournalTropical Medicine and International Health
    Volume20
    Issue number3
    Pages (from-to)322-325
    Number of pages4
    ISSN1360-2276
    DOIs
    Publication statusPublished - 2015

    Fingerprint Dive into the research topics of 'Time to initiation of multidrug-resistant tuberculosis treatment and its relation with outcome in a high incidence district in Lima, Peru'. Together they form a unique fingerprint.

    Cite this